Details
Stereochemistry | ACHIRAL |
Molecular Formula | 2C9H18NS2.Zn |
Molecular Weight | 474.161 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Zn++].CCCCN(CCCC)C([S-])=S.CCCCN(CCCC)C([S-])=S
InChI
InChIKey=BOXSVZNGTQTENJ-UHFFFAOYSA-L
InChI=1S/2C9H19NS2.Zn/c2*1-3-5-7-10(9(11)12)8-6-4-2;/h2*3-8H2,1-2H3,(H,11,12);/q;;+2/p-2
Molecular Formula | C9H19NS2 |
Molecular Weight | 205.384 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | Zn |
Molecular Weight | 65.409 |
Charge | 2 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/6202764Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/689578 | https://www.ncbi.nlm.nih.gov/pubmed/16088893
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6202764
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/689578 | https://www.ncbi.nlm.nih.gov/pubmed/16088893
Zinc dibutyldithiocarbamate (Zn DBDTC) is a vulcanization accelerator for natural rubber and latex and a stabilizer for rubber-based adhesive systems, isobutylene-isoprene copolymers and polypropylene. It is used in a number of rubber and rubber-based materials for food packaging and food handling, e.g. conveyor belts. Zinc dibutyldithiocarbamate (Zn DBDTC) is contact allergens that cross-react in some individuals. Zinc dibutyldithiocarbamate, like many low-molecular-weight contact allergens, can only trigger an immune response when bound to a protein in the form of an immunogenic protein–hapten complex. Haptenation of epidermally relevant skin proteins by Zinc dibutyldithiocarbamate has not been reported despite the numerous studies on the disposition
and systemic toxicity of Zinc dibutyldithiocarbamate. The chelating properties of the dithiocarbamate ligand have been proposed to be responsible for the modification of some metalloproteins and metalloenzymes
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/689578
Groups of 15 male and 15 female rats were given diets contain!ng 0 (control), 100, 500 or 2500 ppm ZnDBDTC for 17wk.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16088893
Model materials of three rubber sheets (Sample C contained ZDBC; thickness, 1 mm) were prepared. Materials were cut into approximately 2 x 15 mm pieces. The pieces (1 g) were put into a centrifuge tube, and 10 mL MEM supplemented with 5% FCS, nonessential amino acids, and 1 mM sodium pyruvate (5% FCS-GMNP) was added. After incubation at 37°C in a humidified atmosphere for 24 h, the extract, designated 100%, was decanted and serially diluted with 5% FCS-GMNP to give 80%, 64%, 51%, and 41% extracts.
Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:35:54 GMT 2025
by
admin
on
Mon Mar 31 21:35:54 GMT 2025
|
Record UNII |
HNM5J934VP
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000185508
Created by
admin on Mon Mar 31 21:35:54 GMT 2025 , Edited by admin on Mon Mar 31 21:35:54 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID0021462
Created by
admin on Mon Mar 31 21:35:54 GMT 2025 , Edited by admin on Mon Mar 31 21:35:54 GMT 2025
|
PRIMARY | |||
|
2906
Created by
admin on Mon Mar 31 21:35:54 GMT 2025 , Edited by admin on Mon Mar 31 21:35:54 GMT 2025
|
PRIMARY | |||
|
136-23-2
Created by
admin on Mon Mar 31 21:35:54 GMT 2025 , Edited by admin on Mon Mar 31 21:35:54 GMT 2025
|
PRIMARY | |||
|
144323
Created by
admin on Mon Mar 31 21:35:54 GMT 2025 , Edited by admin on Mon Mar 31 21:35:54 GMT 2025
|
PRIMARY | |||
|
3880
Created by
admin on Mon Mar 31 21:35:54 GMT 2025 , Edited by admin on Mon Mar 31 21:35:54 GMT 2025
|
PRIMARY | |||
|
36548
Created by
admin on Mon Mar 31 21:35:54 GMT 2025 , Edited by admin on Mon Mar 31 21:35:54 GMT 2025
|
PRIMARY | |||
|
C017801
Created by
admin on Mon Mar 31 21:35:54 GMT 2025 , Edited by admin on Mon Mar 31 21:35:54 GMT 2025
|
PRIMARY | |||
|
HNM5J934VP
Created by
admin on Mon Mar 31 21:35:54 GMT 2025 , Edited by admin on Mon Mar 31 21:35:54 GMT 2025
|
PRIMARY | |||
|
SUB61027
Created by
admin on Mon Mar 31 21:35:54 GMT 2025 , Edited by admin on Mon Mar 31 21:35:54 GMT 2025
|
PRIMARY | |||
|
N0000175629
Created by
admin on Mon Mar 31 21:35:54 GMT 2025 , Edited by admin on Mon Mar 31 21:35:54 GMT 2025
|
PRIMARY | Increased Histamine Release [PE] | ||
|
1426942
Created by
admin on Mon Mar 31 21:35:54 GMT 2025 , Edited by admin on Mon Mar 31 21:35:54 GMT 2025
|
PRIMARY | RxNorm | ||
|
N0000184306
Created by
admin on Mon Mar 31 21:35:54 GMT 2025 , Edited by admin on Mon Mar 31 21:35:54 GMT 2025
|
PRIMARY | Cell-mediated Immunity [PE] | ||
|
8684
Created by
admin on Mon Mar 31 21:35:54 GMT 2025 , Edited by admin on Mon Mar 31 21:35:54 GMT 2025
|
PRIMARY | |||
|
HNM5J934VP
Created by
admin on Mon Mar 31 21:35:54 GMT 2025 , Edited by admin on Mon Mar 31 21:35:54 GMT 2025
|
PRIMARY | |||
|
100000134268
Created by
admin on Mon Mar 31 21:35:54 GMT 2025 , Edited by admin on Mon Mar 31 21:35:54 GMT 2025
|
PRIMARY | |||
|
DB14194
Created by
admin on Mon Mar 31 21:35:54 GMT 2025 , Edited by admin on Mon Mar 31 21:35:54 GMT 2025
|
PRIMARY | |||
|
N0000171131
Created by
admin on Mon Mar 31 21:35:54 GMT 2025 , Edited by admin on Mon Mar 31 21:35:54 GMT 2025
|
PRIMARY | Allergens [Chemical/Ingredient] | ||
|
205-232-8
Created by
admin on Mon Mar 31 21:35:54 GMT 2025 , Edited by admin on Mon Mar 31 21:35:54 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
PARENT -> SALT/SOLVATE |